The  Europe Antibody Specificity Testing Market  was valued at USD 214.94 million in 2024 and is projected to register a CAGR of 7.3% from 2025 to 2034, reaching USD 433.81 million by 2034. The market growth is driven by rising demand for accurate diagnostic assays, increasing biopharmaceutical research, adoption of advanced antibody validation technologies, and strong regulatory...